The Executive Director, Neurology Key Accounts is a senior leadership role responsible for building, leading, and scaling a team of 8 Neurology Account Directors (NADs) supporting the launch and commercialization of Regeneron's C5 inhibitor for generalized myasthenia gravis (gMG).
This leader will establish the institutional neurology accounts team targeting approximately 75
100 academic medical centers (AMCs) and neuromuscular specialty centers.
The Executive Director will serve as the senior commercial interface between Market Access, Commercial Sales, Medical Affairs, and Patient Services to ensure formulary access, competitive access execution, and seamless patient transitions within targeted institutions.
This role requires a rare combination of strategic vision, people leadership, institutional account management expertise, and deep understanding of rare disease and neurology market dynamics.

Bachelor's degree required; advanced degree (MBA, PharmD, PhD) strongly preferred.
Minimum 12+ years pharmaceutical/biotech experience with at least 5 years leading institutional account, market access, patient services, or other account management teams.
Proven track record building and scaling high-performing field account teams, ideally in rare disease, neurology, or specialty biologic environments.
Deep institutional account management expertise including AMC/IDN formulary strategy, P&T committee engagement, and buy-and-bill economics.
Strong strategic planning and analytics capabilities with experience leveraging claims data, commercial intelligence, and market research.
Exceptional cross-functional leadership skills with demonstrated ability to influence across Sales, Medical Affairs, Patient Services, and Payer functions.
Excellent executive communication and presentation skills with experience presenting to senior leadership and external stakeholders.
Preferred Launch leadership experience in rare disease, neurology, or specialty biologic markets.
Direct experience with infusion biologics, complement inhibitors, or autoimmune neurology therapies, or other highly complex advanced therapeutics.
Existing relationships with academic neurology leadership, MGFA-recognized centers, or neuromuscular KOL community.
Understanding of myasthenia gravis disease management, treatment landscape, and patient journey.

health and wellness programs (including medical, dental, vision, life, and disability insurance)
fitness centers
401(k) company match
family support benefits
equity awards
annual bonuses
paid time off
paid leaves (e.g., military and parental leave)

Executive Director, Neurology Key Accounts

Key skills